Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company focused on developing cell therapies for patients with hematologic malignancies and autoimmune diseases. The company uses its chRDNA technology to enable precise genome editing for off-the-shelf CAR-T cell therapies.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.